Corey Casper joined IDRI as its Chief Medical Officer in May 2017. Corey came to IDRI from the Fred Hutchinson Cancer Research Center and the University of Washington, with extensive experience leading multi-phased international clinical trials from conception to publication to U.S. Food and Drug Administration (FDA) licensure. In his role as IDRI’s Chief Medical Officer, Corey is developing and leading all clinical trial programs for IDRI from preclinical to Phase III, including oversight and management of data functions.

Corey has more than 20 years of experience in designing, growing and sustaining internationally-recognized programs in infection-related cancers, HIV, infection control and global oncology. Corey most recently served as a Full Member in the Vaccine and Infectious Disease, Clinical Research and Public Health Sciences Divisions at the Fred Hutchison Cancer Research Center where he founded and directed the one of the nation’s first and most effective outpatient infection control programs; he also founded and directed the first Global Oncology program at a designated comprehensive cancer center. At the University of Washington, Corey was appointed as a Professor of Medicine, Epidemiology and Global Health, and served as the Co-Director of the Center for AIDS Research. Corey has held several clinical positions, including serving as an attending physician for the Seattle Cancer Care Alliance’s Infectious Disease Consult Service.